TwinBeech Capital’s AngioDynamics ANGO Stock Holding History

TwinBeech Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,006	Closed	-$441K	–	595
2022 Q4	$441K	Buy	32,006 +7,885	+33%	+$110K	0.01%	604
2022 Q3	$494K	Buy	+24,121	New	+$530K	0.01%	530
2021 Q3	–	Sell	-11,715	Closed	-$318K	–	566
2021 Q2	$318K	Buy	+11,715	New	+$286K	0.04%	363

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TwinBeech Capital's ANGO Position: Q1 2023 in Review

TwinBeech Capital sold out of AngioDynamics (ANGO) in Q1 2023, closing a stake of 32,006 shares — an estimated $441K sold.

TwinBeech Capital first reported a position in ANGO in Q2 2021 and held it in 3 quarters. The position peaked at $494K in Q3 2022. 153 funds tracked by Wall St. Rank hold ANGO as of Q1 2023.

TwinBeech Capital reported no remaining AngioDynamics position as of Q1 2023 after selling out during the quarter.
TwinBeech Capital sold 32,006 AngioDynamics shares in Q1 2023, an estimated $441K.
TwinBeech Capital first reported a position in AngioDynamics in Q2 2021 and held it in 3 quarters.
TwinBeech Capital's AngioDynamics position peaked at $494K in Q3 2022.
153 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2023.

Based on TwinBeech Capital's 13F filing for Q1 2023, filed 15 May 2023.